Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth

Journal of Cellular and Molecular Medicine - Tập 6 Số 1 - Trang 1-12 - 2002
Jack Lawler1
1Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. [email protected]

Tóm tắt

Thrombospondin‐1 (TSP‐1) is a matricellular glycoprotein that influences cellular phenotype and the structure of the extracellular matrix. These effects are important components of the tissue remodeling that is associated with angiogenesis and neoplasia. The genetic mutations in oncogenes and tumor suppressor genes that occur within tumor cells are frequently associated with decreased expression of TSP‐1. However, the TSP‐1 that is produced by stromal fibroblasts, endothelial cells and immune cells suppresses tumor progression. TSP‐1 inhibits angiogenesis through direct effects on endothelial cell migration and survival and through indirect effects on growth factor mobilization. TSP‐1 that is present in the tumor microenvironment also acts to suppress tumor cell growth through activation of transforming growth factor β in those tumor cells that are responsive to TGFβ. In this review, the molecular basis for the role of TSP‐1 in the inhibition of tumor growth and angiogenesis is summarized.

Từ khóa


Tài liệu tham khảo

Bale M.D., 1985, Incorporation of thrombospondin into fibrin clots, J. Biol. Chem., 260, 7502, 10.1016/S0021-9258(17)39635-7

10.1083/jcb.140.2.419

10.1083/jcb.130.3.503

10.1016/S0945-053X(00)00107-4

Brown L.F., 1999, Vascular stroma formation in carcinoma of the breast, Clin. Cancer Res., 5, 1041

10.1006/jmbi.1997.1510

10.1016/0014-5793(96)00460-7

10.1074/jbc.274.34.24080

10.1074/jbc.274.16.11408

10.1083/jcb.122.2.497

10.1124/mol.55.2.332

10.1126/science.1058040

10.1002/(SICI)1097-0177(200006)218:2<280::AID-DVDY4>3.0.CO;2-0

10.1016/S0955-0674(00)00143-5

10.1016/S1359-6101(99)00029-5

10.1074/jbc.270.13.7304

10.1074/jbc.274.19.13586

10.1172/JCI1684

10.1016/S0092-8674(00)81460-9

10.1074/jbc.275.24.17933

10.1042/0264-6021:3500291

10.1074/jbc.272.26.16329

10.1074/jbc.M008073200

10.1074/jbc.270.4.1729

Lawler J., 1983, Cooperative binding of calcium to thrombospondin, J. Biol. Chem., 258, 12098

Lawler J., 1985, The structure of human platelet thrombospondin, J. Biol. Chem., 260, 3762, 10.1016/S0021-9258(19)83689-X

10.1083/jcb.103.5.1635

10.1083/jcb.118.3.693

10.1074/jbc.271.1.21

Gao A.‐G., 1996, Thrombospondin modulates αvβ3 function through integrin‐associated protein, J. Biol. Chem., 135, 533

10.1083/jcb.146.3.673

BenEzra D., 1993, Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide, Invest. Ophthalmol. Vis. Sci., 34, 3601

10.1083/jcb.124.1.183

10.1161/01.CIR.100.13.1423

Guo N.‐H., 1997, Thrombospondin 1 and type 1 repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells, Cancer Res., 57, 1735

10.1073/pnas.89.7.3040

10.1002/jcb.240530109

10.1074/jbc.274.1.430

10.1006/abbi.1999.1597

10.1083/jcb.138.3.707

10.1038/71517

10.1042/bj3190067

10.1074/jbc.M003969200

10.1182/blood.V97.6.1689

10.1038/sj.onc.1204464

10.1159/000025733

10.1073/pnas.171460498

10.1096/fj.99-0931fje

10.1016/S1471-4914(01)02102-5

10.1046/j.1525-1500.1998.0oa18.x

10.1093/jnci/89.3.219

10.1007/s004280050268

10.1084/jem.191.10.1789

Hsu S.C., 1996, Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin‐1, Cancer Res., 56, 5684

10.1093/nar/28.11.2268

10.1073/pnas.83.23.9050

10.1038/sj.onc.1202654

10.1016/S0002-9440(10)63042-8

10.1016/S1368-8375(00)00048-8

10.1073/pnas.96.5.2065

Clezardin P., 1993, Expression of thrombospondin (TSP‐1) and its receptors (CD36 and CD31) in normal, hyperplastic and neoplastic human breast, Cancer Res., 53, 1421

10.1073/pnas.96.26.14888

Bertin N., 1997, Thrombospondin‐1 and ‐2 messenger RNA expression in normal, benign and neoplastic human breast tissues: Correlation with prognostic factors, tumor angiogenesis and fibroblastic desmoplasia, Cancer Res., 57, 396

10.1159/000055300

10.1038/36978

10.1101/gad.193501